Literature DB >> 20616724

Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules.

Scott A Leddon1, Andrea J Sant.   

Abstract

PURPOSE OF REVIEW: The molecular and cellular mechanisms that underlie allorecognition of MHC class II molecules have been the subject of much debate and experimentation in recent decades. In this review, we discuss several aspects of MHC class II structure, peptide acquisition and TcR-MHC-peptide interactions that have particular relevance to recognition of cells bearing allogeneic class II molecules. RECENT
FINDINGS: First, MHC polymorphism is heavily biased toward those amino acids that influence stable peptide binding by MHC class II. Second, the peptide repertoire presented by class II molecules is highly diverse and can be edited substantially by the molecular catalyst HLA-DM and by tissue-specific expression of HLA-DO, stress and cytokines. Third, T-cell receptor docking onto MHC peptide consistently involves substantial contacts with the bound peptide in the MHC class II molecule. Finally, there is increasing evidence that T-cell recognition of MHC is, in part, germline encoded through T-cell-receptor V region contacts with MHC class II alpha helices.
SUMMARY: Together, these conclusions support the view that allorecognition of MHC class II molecules is likely to parallel key aspects of conventional CD4 T-cell recognition, with allele-dependent variation in peptide representation accounting in large part for the high precursor frequency of alloreactive CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616724      PMCID: PMC3085167          DOI: 10.1097/MOT.0b013e32833bfc5c

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  61 in total

Review 1.  How TCRs bind MHCs, peptides, and coreceptors.

Authors:  Markus G Rudolph; Robyn L Stanfield; Ian A Wilson
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

2.  SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Authors:  N Guex; M C Peitsch
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

Review 3.  Antigen-presenting cells and the selection of immunodominant epitopes.

Authors:  J S Blum; C Ma; S Kovats
Journal:  Crit Rev Immunol       Date:  1997       Impact factor: 2.214

4.  The MHC reactivity of the T cell repertoire prior to positive and negative selection.

Authors:  J Zerrahn; W Held; D H Raulet
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.

Authors:  S Weenink; H Averdunk; T Boston; V Boswarva; J C Guery; L Adorini; E Mellins; J McCluskey; A M Gautam
Journal:  Int Immunol       Date:  1997-06       Impact factor: 4.823

6.  The repertoire of T cells shaped by a single MHC/peptide ligand.

Authors:  L Ignatowicz; J Kappler; P Marrack
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

7.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.

Authors:  M A Sherman; D A Weber; P E Jensen
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

9.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

Authors:  C C Stebbins; G E Loss; C G Elias; A Chervonsky; A J Sant
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.

Authors:  S M van Ham; U Grüneberg; G Malcherek; I Bröker; A Melms; J Trowsdale
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  12 in total

Review 1.  [Human leukocyte antigen (HLA) system in ophthalmology].

Authors:  T Lapp; D Reinhold; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

Review 2.  Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines.

Authors:  Michael W Graner; Kevin O Lillehei; Emmanuel Katsanis
Journal:  Front Oncol       Date:  2015-01-06       Impact factor: 6.244

Review 3.  A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse.

Authors:  Daniel J Firl; Gilles Benichou; James I Kim; Heidi Yeh
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

4.  Transcriptome analysis reveals differences in mechanisms regulating cessation of luteal function in pregnant and non-pregnant dogs.

Authors:  Sophie Zatta; Hubert Rehrauer; Aykut Gram; Alois Boos; Mariusz Pawel Kowalewski
Journal:  BMC Genomics       Date:  2017-09-27       Impact factor: 3.969

5.  Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles.

Authors:  James Robinson; Lisbeth A Guethlein; Nezih Cereb; Soo Young Yang; Paul J Norman; Steven G E Marsh; Peter Parham
Journal:  PLoS Genet       Date:  2017-06-26       Impact factor: 5.917

6.  The peptide specificity of the endogenous T follicular helper cell repertoire generated after protein immunization.

Authors:  Scott A Leddon; Andrea J Sant
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 7.  Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal.

Authors:  Andrea Ferrante
Journal:  Front Immunol       Date:  2013-10-01       Impact factor: 7.561

Review 8.  Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors:  Nicole B Crux; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-07-18       Impact factor: 7.561

9.  Association of human leukocyte antigens-DQB2/DPA1/DPB1 polymorphism and pulmonary tuberculosis in the Chinese Uygur population.

Authors:  Xue Wang; Xudong Cao; Wanjiang Zhang; Le Zhang; Lijun Lu; Xinyue Li; Saeed El-Ashram; Jiangdong Wu; Chuangfu Chen
Journal:  Mol Genet Genomic Med       Date:  2019-01-01       Impact factor: 2.183

10.  HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.

Authors:  Pierpaolo Correale; Rita Emilena Saladino; Diana Giannarelli; Andrea Sergi; Maria Antonietta Mazzei; Giovanna Bianco; Rocco Giannicola; Eleonora Iuliano; Iris Maria Forte; Natale Daniele Calandruccio; Antonia Consuelo Falzea; Alessandra Strangio; Valerio Nardone; Pierpaolo Pastina; Paolo Tini; Amalia Luce; Michele Caraglia; Daniele Caracciolo; Luciano Mutti; Pierfrancesco Tassone; Luigi Pirtoli; Antonio Giordano; Pierosandro Tagliaferri
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.